Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy

Nature Biotechnology

Volumn 33, Issue 9, 2015, Pages 962-969

  Chal, Jerome ^a,b,c,d,e   Oginuma, Masayuki ^a   Al Tanoury, Ziad ^a   Gobert, Benedicte ^a   Sumara, Olga ^a   Hick, Aurore ^f   Bousson, Fanny ^f   Zidouni, Yasmine ^a   Mursch, Caroline ^a   Moncuquet, Philippe ^a   Tassy, Olivier ^a   Vincent, Stephane ^a   Miyanari, Ayako ^a   Bera, Agata ^a   Garnier, Jean Marie ^a   Guevara, Getzabel ^c,d,e   Hestin, Marie ^c,d,e   Kennedy, Leif ^a   Hayashi, Shinichiro ^g,h   Drayton, Bernadette ^g,h   Cherrier, Thomas ^a   Gayraud Morel, Barbara ⁱ   Gussoni, Emanuela ^j   Relaix, Frederic ^g,h   Tajbakhsh, Shahragim ⁱ   Pourquie, Olivier ^a,b,c,d,e,k   more..

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

^f Illkirch Graffenstaden   (France)

^g INSERM   (France)

^h UMRS974 Institut de Myologie   (France)

ⁱ CNRS   (France)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k HOWARD HUGHES MEDICAL INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; FIBERS; MAMMALS; MUSCLE; NEUROMUSCULAR REHABILITATION; NEURONS; STEM CELLS;

DUCHENNE MUSCULAR DYSTROPHIES; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; MONOLAYER CULTURE; PLURIPOTENT STEM CELLS; PRESOMITIC MESODERM; SATELLITE CELLS; SKELETAL MYOGENESIS;

CYTOLOGY;

DYSTROPHIN; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO; EMBRYO DEVELOPMENT; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; MONOLAYER CULTURE; MOUSE; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE DEVELOPMENT; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; ANIMAL; CELL CULTURE; DISEASE MODEL; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; MICE; MICE, TRANSGENIC; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PLURIPOTENT STEM CELLS;

EID: 84941053453     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3297     Document Type: Article

References (69)

1. Rinaldi, F., Perlingeiro, R.C. Stem cells for skeletal muscle regeneration: therapeutic potential and roadblocks. Transl. Res. 163, 409-417 (2013).
2. Darabi, R. et al. Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10, 610-619 (2012).
3. Darabi, R. et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med. 14, 134-143 (2008).
4. Albini, S. et al. Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres. Cell Reports 3, 661-670 (2013).
5. Salani, S. et al. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies. J. Cell. Mol. Med. 16, 1353-1364 (2012).
6. Tanaka, A. et al. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS ONE 8, e61540 (2013).
7. Abujarour, R. et al. Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery. Stem Cells Transl. Med. 3, 149-160 (2014).
8. Braun, T., Arnold, H.H. ES-cells carrying two inactivated myf-5 alleles form skeletal muscle cells: activation of an alternative myf-5-independent differentiation pathway. Dev. Biol. 164, 24-36 (1994).
9. Rohwedel, J. et al. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol. 164, 87-101 (1994).
10. Braun, T., Arnold, H.H. Myf-5 and myoD genes are activated in distinct mesenchymal stem cells and determine different skeletal muscle cell lineages. EMBO J. 15, 310-318 (1996).
11. Zheng, J.K. et al. Skeletal myogenesis by human embryonic stem cells. Cell Res. 16, 713-722 (2006).
12. Mizuno, Y. et al. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J. 24, 2245-2253 (2010).
13. Tanaka, M. et al. BMP inhibition stimulates WNT-dependent generation of chondrogenic mesoderm from embryonic stem cells. Stem Cell Res. (Amst.) 3, 126-141 (2009).
14. Hwang, Y. et al. Directed in vitro myogenesis of human embryonic stem cells and their in vivo engraftment. PLoS ONE 8, e72023 (2013).
15. Chang, H. et al. Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells. FASEB J. 23, 1907-1919 (2009).
16. Xu, C. et al. A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. Cell 155, 909-921 (2013).
17. Sakurai, H. et al. In vitro modeling of paraxial mesodermal progenitors derived from induced pluripotent stem cells. PLoS ONE 7, e47078 (2012).
18. Sakurai, H. et al. Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium. Stem Cell Res. (Amst.) 3, 157-169 (2009).
19. Sakurai, H., Okawa, Y., Inami, Y., Nishio, N., Isobe, K. Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Stem Cells 26, 1865-1873 (2008).
20. Borchin, B., Chen, J., Barberi, T. Derivation and FACS-mediated purification of PAX3+/PAX7+ skeletal muscle precursors from human pluripotent stem cells. Stem Cell Reports 1, 620-631 (2013).
21. Hosoyama, T., McGivern, J.V., Van Dyke, J.M., Ebert, A.D., Suzuki, M. Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture. Stem Cells Transl. Med. 3, 564-574 (2014).
22. Gouti, M. et al. In vitro generation of neuromesodermal progenitors reveals distinct roles for wnt signalling in the specification of spinal cord and paraxial mesoderm identity. PLoS Biol. 12, e1001937 (2014).
23. Tan, J.Y., Sriram, G., Rufaihah, A.J., Neoh, K.G., Cao, T. Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi-mediated differentiation. Stem Cells Dev. 22, 1893-1906 (2013).
24. Shelton, M. et al. Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells. Stem Cell Rev. 3, 516-529 (2013).
25. Ozbudak, E.M., Tassy, O., Pourquie, O. Spatiotemporal compartmentalization of key physiological processes during muscle precursor differentiation. Proc. Natl. Acad. Sci. USA 107, 4224-4229 (2010).
26. Wittler, L. et al. Expression of Msgn1 in the presomitic mesoderm is controlled by synergism of WNT signalling and Tbx6. EMBO Rep. 8, 784-789 (2007).
27. Kazanskaya, O. et al. R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Dev. Cell 7, 525-534 (2004).
28. Tonegawa, A., Funayama, N., Ueno, N., Takahashi, Y. Mesodermal subdivision along the mediolateral axis in chicken controlled by different concentrations of BMP-4. Development 124, 1975-1984 (1997).
29. Hutcheson, D.A., Zhao, J., Merrell, A., Haldar, M., Kardon, G. Embryonic and fetal limb myogenic cells are derived from developmentally distinct progenitors and have different requirements for beta-catenin. Genes Dev. 23, 997-1013 (2009).
30. Chargé, S.B., Rudnicki, M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238 (2004).
31. White, R.B., Bierinx, A.S., Gnocchi, V.F., Zammit, P.S. Dynamics of muscle fibre growth during postnatal mouse development. BMC Dev. Biol. 10, 21 (2010).
32. Messina, G. et al. Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell 140, 554-566 (2010).
33. Relaix, F., Rocancourt, D., Mansouri, A., Buckingham, M.A. Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435, 948-953 (2005).
34. Sambasivan, R., Tajbakhsh, S. Skeletal muscle stem cell birth and properties. Semin. Cell Dev. Biol. 18, 870-882 (2007).
35. Rahimov, F., Kunkel, L.M. The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J. Cell Biol. 201, 499-510 (2013).
36. Allen, D.G., Whitehead, N.P. Duchenne muscular dystrophy-what causes the increased membrane permeability in skeletal muscle? Int. J. Biochem. Cell Biol. 43, 290-294 (2011).
37. Matsuda, R., Nishikawa, A., Tanaka, H. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. 118, 959-964 (1995).
38. Friedrich, O. et al. Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle. Biophys. J. 98, 606-616 (2010).
39. Minami, I. et al. A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine-and xeno-free conditions. Cell Rep. 2, 1448-1460 (2012).
40. Biressi, S., Molinaro, M., Cossu, G. Cellular heterogeneity during vertebrate skeletal muscle development. Dev. Biol. 308, 281-293 (2007).
41. Eiraku, M. et al. Self-organizing optic-cup morphogenesis in three-dimensional culture. Nature 472, 51-56 (2011).
42. McCracken, K.W. et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516, 400-404 (2014).
43. Li, W., Ding, S. Human pluripotent stem cells: decoding the naive state. Sci. Transl. Med. 3, 76ps10 (2011).
44. Merrick, D., Stadler, L.K., Larner, D., Smith, J. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis. Model. Mech. 2, 374-388 (2009).
45. Chan, S., Head, S.I. The role of branched fibres in the pathogenesis of Duchenne muscular dystrophy. Exp. Physiol. 96, 564-571 (2011).
46. Goodall, M.H., Ward, C.W., Pratt, S.J., Bloch, R.J., Lovering, R.M. Structural and functional evaluation of branched myofibers lacking intermediate filaments. Am. J. Physiol. Cell Physiol. 303, C224-C232 (2012).
47. Pavlath, G.K. A new function for odorant receptors: MOR23 is necessary for normal tissue repair in skeletal muscle. Cell Adh. Migr. 4, 502-506 (2010).
48. Montarras, D. et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309, 2064-2067 (2005).
49. Mouly, V. et al. Myoblast transfer therapy: is there any light at the end of the tunnel? Acta Myol. 24, 128-133 (2005).
50. Collins, C.A. et al. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122, 289-301 (2005).
51. Yasuhiko, Y. et al. Tbx6-mediated Notch signaling controls somite-specific Mesp2 expression. Proc. Natl. Acad. Sci. USA 103, 3651-3656 (2006).
52. Nagai, T. et al. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 87-90 (2002).
53. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., Roder, J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428 (1993).
54. Relaix, F. et al. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev. 17, 2950-2965 (2003).
55. Kress, C., Vandormael-Pournin, S., Baldacci, P., Cohen-Tannoudji, M., Babinet, C. Nonpermissiveness for mouse embryonic stem (ES) cell derivation circumvented by a single backcross to 129/Sv strain: establishment of ES cell lines bearing the Omd conditional lethal mutation. Mamm. Genome 9, 998-1001 (1998).
56. Cheng, T.C., Wallace, M.C., Merlie, J.P., Olson, E.N. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 261, 215-218 (1993).
57. Sambasivan, R. et al. Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates. Dev. Cell 16, 810-821 (2009).
58. Ying, Q.L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-523 (2008).
59. Boulting, G.L. et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29, 279-286 (2011).
60. Thomson, J.A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
61. Dequeánt, M.L. et al. A complex oscillating network of signaling genes underlies the mouse segmentation clock. Science 314, 1595-1598 (2006).
62. Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500-501 (2006).
63. Tassy, O., Pourquie, O. Manteia, a predictive data mining system for vertebrate genes and its applications to human genetic diseases. Nucleic Acids Res. 42 (Database issue), D882-D891 (2014).
64. Henrique, D. et al. Expression of a Delta homologue in prospective neurons in the chick. Nature 375, 787-790 (1995).
65. Saga, Y., Hata, N., Koseki, H., Taketo, M.M. Mesp2: a novel mouse gene expressed in the presegmented mesoderm and essential for segmentation initiation. Genes Dev. 11, 1827-1839 (1997).
66. Niederreither, K., Subbarayan, V., Dolle, P., Chambon, P. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat. Genet. 21, 444-448 (1999).
67. Crossley, P.H., Martin, G.R. The mouse Fgf8 gene encodes a family of polypeptides and is expressed in regions that direct outgrowth and patterning in the developing embryo. Development 121, 439-451 (1995).
68. Mathew, S.J. et al. Connective tissue fibroblasts and Tcf4 regulate myogenesis. Development 138, 371-384 (2011).
69. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012).